Bullish option flow detected in Capricor Therapeutics with 7,539 calls trading, 2x expected, and implied vol increasing over 1 point to 140.84%. Oct-24 20 calls and Jan-25 5 calls are
Bullish option flow detected in Capricor Therapeutics with 7,539 calls trading, 2x expected, and implied vol increasing over 1 point to 140.84%. Oct-24 20 calls and Jan-25 5 calls are
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Moleculin Biotech (MBRX), 3,067% surge in interest Elevai Labs
Maxim analyst Jason McCarthy raised the firm’s price target on Capricor Therapeutics to $25 from $12 and keeps a Buy rating on the shares. The firm cites the company having
Oppenheimer העלו את מחיר היעד שלהם עבור Capricor Therapeutics מ-15 ליש”ט ל-43 ליש”ט וממשיכים להמליץ על רכישת המניה. הם עדכנו את מודל הכספים שלהם לאחר עדכון חיובי מהרגולטורים, שמרמז על
Oppenheimer raised the firm’s price target on Capricor Therapeutics to $43 from $15 and keeps an Outperform rating on the shares. The firm has revised its model following the highly